Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1994 Feb;71(2):115–118. doi: 10.1136/hrt.71.2.115

Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial.

M S Sutton 1
PMCID: PMC483628  PMID: 8130017

Full text

PDF
115

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahnve S., Gilpin E., Henning H., Curtis G., Collins D., Ross J., Jr Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarction. Am J Cardiol. 1986 Nov 1;58(10):872–878. doi: 10.1016/s0002-9149(86)80002-9. [DOI] [PubMed] [Google Scholar]
  2. Braunwald E., Kloner R. A. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982 Dec;66(6):1146–1149. doi: 10.1161/01.cir.66.6.1146. [DOI] [PubMed] [Google Scholar]
  3. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  4. Dawson J. Easeful death. Br Med J (Clin Res Ed) 1986 Nov 8;293(6556):1187–1188. doi: 10.1136/bmj.293.6556.1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gøtzsche C. O., Søgaard P., Ravkilde J., Thygesen K. Effects of captopril on left ventricular systolic and diastolic function after acute myocardial infarction. Am J Cardiol. 1992 Jul 15;70(2):156–160. doi: 10.1016/0002-9149(92)91268-9. [DOI] [PubMed] [Google Scholar]
  6. Hammermeister K. E., DeRouen T. A., Dodge H. T. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation. 1979 Mar;59(3):421–430. doi: 10.1161/01.cir.59.3.421. [DOI] [PubMed] [Google Scholar]
  7. Heusch G. Alpha-adrenergic mechanisms in myocardial ischemia. Circulation. 1990 Jan;81(1):1–13. doi: 10.1161/01.cir.81.1.1. [DOI] [PubMed] [Google Scholar]
  8. Jeremy R. W., Hackworthy R. A., Bautovich G., Hutton B. F., Harris P. J. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol. 1987 May;9(5):989–995. doi: 10.1016/s0735-1097(87)80298-x. [DOI] [PubMed] [Google Scholar]
  9. Jugdutt B. I., Warnica J. W. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location. Circulation. 1988 Oct;78(4):906–919. doi: 10.1161/01.cir.78.4.906. [DOI] [PubMed] [Google Scholar]
  10. Kloner R. A., Parisi A. F. Acute myocardial infarction: diagnostic and prognostic applications of two-dimensional echocardiography. Circulation. 1987 Mar;75(3):521–524. doi: 10.1161/01.cir.75.3.521. [DOI] [PubMed] [Google Scholar]
  11. Marino P., Zanolla L., Zardini P. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial. J Am Coll Cardiol. 1989 Nov 1;14(5):1149–1158. doi: 10.1016/0735-1097(89)90409-9. [DOI] [PubMed] [Google Scholar]
  12. Morgan C. D., Roberts R. S., Haq A., Baigrie R. S., Daly P. A., Gent M., Armstrong P. W. Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study Group. J Am Coll Cardiol. 1991 Jun;17(7):1451–1457. doi: 10.1016/0735-1097(91)90630-r. [DOI] [PubMed] [Google Scholar]
  13. Moss A. J., Oakes D., Rubison M., McDermott M., Carleen E., Eberly S., Brown M. Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group. Am J Cardiol. 1991 Aug 15;68(5):429–433. doi: 10.1016/0002-9149(91)90773-e. [DOI] [PubMed] [Google Scholar]
  14. Nabel E. G., Topol E. J., Galeana A., Ellis S. G., Bates E. R., Werns S. W., Walton J. A., Muller D. W., Schwaiger M., Pitt B. A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction. J Am Coll Cardiol. 1991 Feb;17(2):467–473. doi: 10.1016/s0735-1097(10)80117-2. [DOI] [PubMed] [Google Scholar]
  15. Oldroyd K. G., Pye M. P., Ray S. G., Christie J., Ford I., Cobbe S. M., Dargie H. J. Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction. Am J Cardiol. 1991 Sep 15;68(8):713–718. doi: 10.1016/0002-9149(91)90641-w. [DOI] [PubMed] [Google Scholar]
  16. Olivetti G., Capasso J. M., Sonnenblick E. H., Anversa P. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res. 1990 Jul;67(1):23–34. doi: 10.1161/01.res.67.1.23. [DOI] [PubMed] [Google Scholar]
  17. Pfeffer J. M., Pfeffer M. A., Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985 Jul;57(1):84–95. doi: 10.1161/01.res.57.1.84. [DOI] [PubMed] [Google Scholar]
  18. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  19. Pfeffer M. A., Pfeffer J. M., Steinberg C., Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 1985 Aug;72(2):406–412. doi: 10.1161/01.cir.72.2.406. [DOI] [PubMed] [Google Scholar]
  20. Sharpe N., Smith H., Murphy J., Greaves S., Hart H., Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet. 1991 Apr 13;337(8746):872–876. doi: 10.1016/0140-6736(91)90202-z. [DOI] [PubMed] [Google Scholar]
  21. Swedberg K., Held P., Kjekshus J., Rasmussen K., Rydén L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med. 1992 Sep 3;327(10):678–684. doi: 10.1056/NEJM199209033271002. [DOI] [PubMed] [Google Scholar]
  22. Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES